Table 4 Intermediate and cumulative system effectiveness for the delivery of IPTp with and without directly observed therapy (DOT) through the antenatal care platform
From: Effectiveness of the delivery of interventions to prevent malaria in pregnancy in Kenya
Level 4 | Levels 3 and 2 | |||||
|---|---|---|---|---|---|---|
n | Intermediate | Cumulative | n | Intermediate | Cumulative | |
% (95 % CI) | % (95 % CI) | % (95 % CI) | % (95 % CI) | |||
With DOT | ||||||
IPTp eligiblea | 304 | 242 | ||||
SP in stock | 304 | 100.0 | 100.0 | 242 | 100.0 | 100.0 |
Receive SP during visit | 208 | 68.6 [60.2, 75.9] | 68.6 [60.2, 75.9] | 198 | 80.3 [61.7, 91.1] | 80.3 [61.7, 91.1] |
Receive three doses SP during visit | 206 | 99.0 [96.1, 99.7] | 67.8 [60.6, 74.3] | 187 | 94.1 [77.5, 98.7] | 75.5 [55.4, 88.5] |
Took SP by DOT | 121 | 64.6 [22.2, 92.1] | 39.8 [12.5, 75.4] | 129 | 70.1 [22.1, 95.1] | 53.3 [21.0, 83.1] |
With or without DOTb | ||||||
IPTp eligiblea | 208 | 220 | ||||
SP in stock | 208 | 100.0 | 100.0 | 220 | 100.0 | 100.0 |
Being given SP during visit | 140 | 67.5 [60.3, 74.0] | 67.5 [60.3, 74.0] | 181 | 79.7 [60.8, 90.9] | 79.7 [60.8, 90.9] |
Being given three doses SP during visit | 139 | 99.2 [96.2, 99.9] | 67.0 [60.6, 72.8] | 170 | 93.4 [74.5, 98.6] | 74.5 [53.6, 88.1] |
Has SP on exit | 52 | 88.0 [63.3, 96.9] | 40.3 [18.2, 67.2] | 50 | 93.4 [45.9, 99.6] | 54.0 [17.6, 86.5] |
Knows to take three tablets SP | 48 | 92.1 [78.1, 97.5] | 37.2 [17.7, 61.9] | 49 | 96.4 [59.6, 99.8] | 52.5 [16.3, 86.2] |
SP by DOT | 80 | 58.3 [19.3, 89.1] | 39.1 [15.9, 68.6] | 118 | 71.0 [22.9, 95.3] | 52.9 [20.2, 83.2] |
Knows to take three tablets SP or took SP as DOT | 128 | 92.1 [87.4, 95.1] | 61.7 [55.7, 67.4] | 167 | 97.1 [70.6, 99.8] | 72.3 [46.9, 88.6] |